European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
Large variation in ESBL-producing Escherichia coli carriers in six European countries including Russia.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ny Sofia, Kozlov Roman, Dumpis Uga, Edquist Petra, Gröndahl-Yli-Hannuksela Kirsi, Kling Anna-Maria, Lis Danuta O, Lübbert Christoph, Pomorska-Wesołowska Monika, Palagin Ivan, Vilde Aija, Vuopio Jaana, Walter Jan, Wisell Karin Tegmark, NoDARS ESBL-carrier working group
Аннотация
We investigated the faecal carriage prevalence of extended-spectrum β-lactamase production in Escherichia coli (EP-EC) and/or Klebsiella pneumoniae (EP-KP) and risk factors associated with carriage among adult study subjects in Finland, Germany, Latvia, Poland, Russia and Sweden (partner countries). The aim was to get indicative data on the prevalence of ESBL-carriage in specific populations in the region. Faecal samples were collected from four study populations and screened on ChromID-ESBL and ChromID-OXA-48 plates. Positive isolates were further characterised phenotypically. Our results show a large variation in carrier prevalence ranging from 1.6% in Latvia to 23.2% in Russia for EP-EC. For the other partner countries, the prevalence of EP-EC were in increasing numbers, 2.3% for Germany, 4.7% for Finland, 6.6% for Sweden, 8.0% for Poland and 8.1% for all partner countries in total. Carriers of EP-KP were identified only in Finland, Russia and Sweden, and the prevalence was < 2% in each of these countries. No carriers of carbapenemase-producing isolates were identified. This is the first study reporting prevalence of carriers (excluding traveller studies) for Finland, Latvia, Poland and Russia. It contributes with important information regarding the prevalence of EP-EC and EP-KP carriage in regions where studies on carriers are limited.
Предметные рубрики MeSH
AdultAnti-Bacterial AgentsAsymptomatic InfectionsBacterial ProteinsCross-Sectional StudiesDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsEuropeFecesFemaleHumansKlebsiella InfectionsKlebsiella pneumoniaeMaleMicrobial Sensitivity TestsMiddle AgedPrevalenceRisk FactorsRussiaYoung Adultbeta-Lactamases